40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
10.98%
Similar revenue growth to VET's 10.79%. Walter Schloss would investigate if similar growth reflects similar quality.
-1.84%
Cost reduction while VET shows 11.99% growth. Joel Greenblatt would examine competitive advantage.
25.49%
Gross profit growth exceeding 1.5x VET's 10.20%. David Dodd would verify competitive advantages.
13.07%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.11%
Other expenses growth less than half of VET's 1474.87%. David Dodd would verify if advantage is sustainable.
1.91%
Operating expenses growth less than half of VET's 8.17%. David Dodd would verify sustainability.
-0.80%
Total costs reduction while VET shows 9.94% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
6.38%
D&A growth less than half of VET's 15.10%. David Dodd would verify if efficiency is sustainable.
29.29%
EBITDA growth exceeding 1.5x VET's 14.02%. David Dodd would verify competitive advantages.
-6.45%
EBITDA margin decline while VET shows 2.92% growth. Joel Greenblatt would examine position.
44.01%
Operating income growth exceeding 1.5x VET's 12.87%. David Dodd would verify competitive advantages.
29.76%
Operating margin growth exceeding 1.5x VET's 1.88%. David Dodd would verify competitive advantages.
84.18%
Other expenses growth less than half of VET's 247.24%. David Dodd would verify if advantage is sustainable.
165.05%
Pre-tax income growth exceeding 1.5x VET's 51.40%. David Dodd would verify competitive advantages.
138.82%
Pre-tax margin growth exceeding 1.5x VET's 36.65%. David Dodd would verify competitive advantages.
96.50%
Tax expense growth less than half of VET's 267.78%. David Dodd would verify if advantage is sustainable.
190.57%
Net income growth exceeding 1.5x VET's 30.95%. David Dodd would verify competitive advantages.
161.81%
Net margin growth exceeding 1.5x VET's 18.20%. David Dodd would verify competitive advantages.
193.54%
EPS growth exceeding 1.5x VET's 29.17%. David Dodd would verify competitive advantages.
195.00%
Diluted EPS growth exceeding 1.5x VET's 27.66%. David Dodd would verify competitive advantages.
-8.98%
Share count reduction while VET shows 1.37% change. Joel Greenblatt would examine strategy.
-9.50%
Diluted share reduction while VET shows 1.20% change. Joel Greenblatt would examine strategy.
